Perrigo Balance Sheet Health
Financial Health criteria checks 3/6
Perrigo has a total shareholder equity of $4.6B and total debt of $4.8B, which brings its debt-to-equity ratio to 104.8%. Its total assets and total liabilities are $11.2B and $6.6B respectively. Perrigo's EBIT is $240.4M making its interest coverage ratio 1.1. It has cash and short-term investments of $1.5B.
Key information
104.8%
Debt to equity ratio
US$4.78b
Debt
| Interest coverage ratio | 1.1x |
| Cash | US$1.46b |
| Equity | US$4.57b |
| Total liabilities | US$6.64b |
| Total assets | US$11.20b |
Recent financial health updates
These 4 Measures Indicate That Perrigo (NYSE:PRGO) Is Using Debt Extensively
May 29
These 4 Measures Indicate That Perrigo (NYSE:PRGO) Is Using Debt Extensively
Feb 01Recent updates
Perrigo (NYSE:PRGO) Has Announced A Dividend Of $0.276
Nov 07Improved Revenues Required Before Perrigo Company plc (NYSE:PRGO) Shares Find Their Feet
Oct 18Perrigo (NYSE:PRGO) Is Due To Pay A Dividend Of $0.276
Aug 21The Play On Perrigo
Aug 16Perrigo (NYSE:PRGO) Has Announced A Dividend Of $0.276
Aug 07Improved Revenues Required Before Perrigo Company plc (NYSE:PRGO) Shares Find Their Feet
Jul 03These 4 Measures Indicate That Perrigo (NYSE:PRGO) Is Using Debt Extensively
May 29Benign Growth For Perrigo Company plc (NYSE:PRGO) Underpins Its Share Price
Mar 27These 4 Measures Indicate That Perrigo (NYSE:PRGO) Is Using Debt Extensively
Feb 01The Market Doesn't Like What It Sees From Perrigo Company plc's (NYSE:PRGO) Revenues Yet
Dec 28Perrigo's New Chapter: Its Bold Turnaround Plan Is Worth Buying
Nov 15The Prognosis For Perrigo
Aug 30Perrigo Outlook Healed By Repositioning
Jun 12Perrigo raises dividend by 5% to $0.273/share
Feb 21Perrigo: Still Languishing But Short-Term Trend Offers Encouragement
Jan 18Perrigo Non-GAAP EPS of $0.56 misses by $0.11, revenue of $1.1B misses by $40M, lowers FY adj. EPS guidance
Nov 08Perrigo to invest $170M to expand baby formula manufacturing, buys Nestlé Gateway plant
Nov 01Perrigo Company plc Is Back On Track
Oct 20Perrigo to face FDA AdCom meeting for OTC contraceptive
Sep 12Perrigo responds to 'misleading and inaccurate information' on Zantac claims
Aug 17Perrigo reports Q2 mixed results; raises FY22 organic net sales growth outlook
Aug 09Perrigo declares $0.26 dividend
Aug 02Perrigo: HRA Acquisition To Drive Significant Growth
Jul 20Perrigo unit seeks FDA over-the-counter approval for birth control pill Opill
Jul 11Financial Position Analysis
Short Term Liabilities: PRGO's short term assets ($3.7B) exceed its short term liabilities ($1.5B).
Long Term Liabilities: PRGO's short term assets ($3.7B) do not cover its long term liabilities ($5.2B).
Debt to Equity History and Analysis
Debt Level: PRGO's net debt to equity ratio (72.8%) is considered high.
Reducing Debt: PRGO's debt to equity ratio has increased from 58% to 104.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable PRGO has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: PRGO is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 11.9% per year.